The activity assessment of P450c17 enzyme variants identified in the patients with testicular tumors revealed a severe enzymatic impairment and androgen production abolishment (Table 3) in all but one (p.Leu476Pro variant), for whom the information was not available. This evidence concerns the gene CYP17A1 and neoplasm of testis.